$CLDX: Celldex Presents Emerging MerTK Antibody Program at the Society …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented data from the Company’s MerTK antibody program in a poster session …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675543/celldex-presents-emerging-mertk-antibody-program-at-the-society-for-im

Related News:

$CLDX: Why Is Celldex (CLDX) Down 29.2% Since Last Earnings Report?

$LLY $CLDX $ACOR $ANIK: Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down

$CLDX: Celldex Announces Data from CDX-3379 Clinical Program …

$CLDX: Celldex Therapeutics Continues to Stretch Out Its Cash and …

$CLDX: Celldex (CLDX) Down 5.7% Since Last Earnings Report: Can It Rebound?

$CLDX: Celldex (CLDX) Down 5.7% Since Last Earnings Report: Can It Rebound?

$CLDX: Celldex (CLDX) Down 5.7% Since Last Earnings Report: Can It Rebound?

$LLY $BMY $CELG $CLDX: Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat

$CLDX: Celldex Therapeutics’ Cost-Cutting and Reverse Stock Split Help …

$CLDX: Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 …

$CLDX: Celldex Therapeutics, Inc (CLDX) Q4 2018 Earnings Conference …

Latest News:

$KO $PEP $CLX $BDX $ECL: Coca-Cola, PepsiCo break ties with plastic lobbying group amid mounting scrutiny over pollution

$VFC: VF Expected to Earn 29 Cents a Share

$SJM: The JM Smucker Company Announces Dividend Increase

$CNI: Canadian National Sees Higher Profit In The Second Quarter

$SJM: JM Smucker declares $0.88 dividend

$SNAP: Snap Earnings: SNAP Stock Skyrockets 11% as Sales Gain Nearly …

$EDF: Stone Harbor Emerging Markets Income Fund declares $0.18 dividend

$EDI: Stone Harbor Emerging Markets Total Income Fund declares …

$FCBC: First Community Bancshares declares $0.25 dividend

$EFX $MSFT: Cybersecurity Stocks Vie for a Slice of a Trillion-Dollar Market

$CB: Chubb Q2 EPS beats as net premiums rise Y/Y